| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Revenue | $17.4B | $15.8B | $14.3B | $13.4B | $12.6B | $3.1B | $2.9B | $2.8B |
| Cost of Revenue | — | — | — | — | — | — | — | — |
| Gross Profit | — | — | — | — | — | — | — | — |
| R&D Expense | — | — | — | — | — | — | — | — |
| SG&A Expense | — | — | — | — | — | — | — | — |
| Operating Income | $2.0B | $1.7B | $1.2B | $1.0B | $1.4B | $1.4B | $1.2B | $1.2B |
| Net Income | $1.5B | $1.1B | $0.7B | $0.7B | $1.0B | $0.3B | $0.2B | $0.2B |
| EPS (Basic) | $23.42 | $17.16 | $10.35 | $9.23 | $11.99 | $3.63 | $2.81 | $1.71 |
| EPS (Diluted) | $23.10 | $16.82 | $10.23 | $9.14 | $11.82 | $3.60 | $2.79 | $1.70 |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $15.5B | $14.5B | $14.0B | $13.5B | $13.1B | $13.5B | $11.7B | $11.3B |
| Current Assets | $3.4B | $2.8B | $2.8B | $2.5B | $2.3B | $3.3B | $1.9B | $1.9B |
| Cash & Equivalents | $0.1B | $0.1B | $0.1B | $0.1B | $0.1B | $1.2B | $0.1B | $0.1B |
| Total Liabilities | — | — | — | — | — | — | — | — |
| Current Liabilities | $3.2B | $2.2B | $2.0B | $1.9B | $2.0B | $2.5B | $1.6B | $1.4B |
| Stockholders' Equity | $7.3B | $6.7B | $6.1B | $5.9B | $6.1B | $6.3B | $5.5B | $5.4B |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $1.9B | $2.1B | $1.3B | $1.0B | $0.9B | $2.4B | $1.4B | $1.3B |
| Investing Cash Flow | $-1.1B | $-0.9B | $-0.8B | $-0.6B | $-0.9B | $-0.8B | $-0.7B | $-0.8B |
| Capital Expenditures | $1.0B | $0.9B | $0.7B | $0.7B | $0.9B | $0.7B | $0.6B | $0.7B |
| Financing Cash Flow | $-0.7B | $-1.1B | $-0.5B | $-0.3B | $-1.1B | $-0.4B | $-0.8B | $-0.5B |